AstraZeneca to Buy Alexion in $39 Billion Deal
2:49
Bloomberg.com
AstraZeneca to Buy Alexion in $39 Billion Deal
AstraZeneca Plc agreed to buy Alexion Pharmaceuticals Inc. for $39 billion, pushing the U.K. company, which has built a turnaround on its strength in oncology, into new areas such as immunology. Sam Fazeli of Bloomberg Intelligence has the latest on "Bloomberg Surveillance." (Source: Bloomberg)
Dec 14, 2020
Related Products
Alexion AstraZeneca Deal
Alexion AstraZeneca Image Email Sign
Alexion AstraZeneca Logo
#Alexion Pharmaceuticals Products
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion Pharmaceuticals, Inc. | LinkedIn
linkedin.comJan 1, 2009
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
Alexion Pharmaceuticals, Inc. Vise à faire progresser le paysage des traitements de la Nmosd avec des données exceptionnelles sur l'efficacité d'Ultomiris® (Ravulizumab-Cwvz) à Ectrims 2022
zonebourse.comOct 12, 2022
Top videos
AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal
3:36
AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal
CNBC
Dec 14, 2020
AstraZeneca eyes big jump in revenue after Alexion acquisition
AstraZeneca eyes big jump in revenue after Alexion acquisition
proactiveinvestors.co.uk
Jul 29, 2021
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceuticals
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceuticals
thestreet.com
Dec 12, 2020
Alexion Pharmaceuticals Acquisitions
Alexion CEO: We are thrilled with FDA approval
Alexion CEO: We are thrilled with FDA approval
CNBC
Jun 30, 2017
Typically diagnosed in early childhood, #Neurofibromatosis type 1 (NF1) is a rare, progressive, genetic condition that involves the development of nonmalignant tumours that may affect the brain, spinal cord and nerves. | Alexion Pharmaceuticals
0:09
Typically diagnosed in early childhood, #Neurofibromatosis type 1 (NF1) is a rare, progressive, genetic condition that involves the development of nonmalignant tumours that may affect the brain, spinal cord and nerves. | Alexion Pharmaceuticals
FacebookAlexion Pharmaceuticals
38 views3 weeks ago
Alexion Pharmaceuticals, Inc. | Sung-Kwon Kim
Alexion Pharmaceuticals, Inc. | Sung-Kwon Kim
linkedin.com
1 viewsJun 28, 2019
AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal
3:36
AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal
Dec 14, 2020
CNBC
AstraZeneca eyes big jump in revenue after Alexion acquisition
AstraZeneca eyes big jump in revenue after Alexion acquisition
Jul 29, 2021
proactiveinvestors.co.uk
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceuticals
AstraZeneca Agrees $39 Billion Takeover of Alexion Pharmaceutic…
Dec 12, 2020
thestreet.com
Astrazeneca takes £13bn loan to fund Alexion deal
Astrazeneca takes £13bn loan to fund Alexion deal
Dec 13, 2020
thisismoney.co.uk
Acuerdo con AstraZeneca impulsa acciones de Alexion
Acuerdo con AstraZeneca impulsa acciones de Alexion
Sep 1, 2020
elceo.com
AstraZeneca To Buy Former CT-Based Alexion In $39 Billion Deal
AstraZeneca To Buy Former CT-Based Alexion In $39 Billion Deal
Dec 12, 2020
patch.com
UK nod paves way for AstraZeneca-Alexion deal to close next week
2:45
UK nod paves way for AstraZeneca-Alexion deal to close next week
Jul 14, 2021
ReutersReuters
0:18
Today we announced the completion of AstraZeneca’s acqu…
1.3K viewsJul 21, 2021
FacebookAstraZeneca
Alexion Pharmaceuticals, Inc. | LinkedIn
Jan 1, 2009
linkedin.com
3:44
AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal
7K viewsDec 14, 2020
YouTubeCNBC Television
Is AstraZeneca Paying Too Much for Alexion? | The Motley Fool
Dec 21, 2020
fool.com
1:32
Life At Alexion: Being Part of AstraZeneca
2.4K viewsMay 3, 2022
YouTubeAlexion Pharmaceuticals, Inc.
4:37
Alexion Pharmaceuticals to Move From New Haven to Boston
Sep 11, 2017
nbcconnecticut.com
AstraZeneca shares dip after $39 bln Alexion deal
1.4K viewsDec 14, 2020
YouTubeReuters
0:46
Pfizer and AstraZeneca vaccines approved for booster scheme
Sep 30, 2021
Express.co.ukJacob Paul
AstraZeneca (AZN) to Buy Full Stake in Rare Disease Drugmaker
Oct 1, 2021
nasdaq.com
1:35
Explainer: How the AstraZeneca-Oxford COVID vaccine works
15K viewsDec 25, 2020
YouTubeNews Direct
1:08
AstraZeneca says trials of coronavirus vaccine resume
51.4K viewsSep 12, 2020
YouTubeReuters
1:17
13K views · 179 reactions | Infectious disease specialist Dr. Is…
13.4K views2 weeks ago
FacebookCTV News
2:06
Alexion, AstraZeneca Rare Disease: Who We Are
1.4K viewsAug 2, 2024
YouTubeAlexion Pharmaceuticals, Inc.
1:13
AstraZeneca shares dip after $39 bln Alexion deal
Dec 14, 2020
YahooReuters Videos
#whatsciencecando | AstraZeneca
2 months ago
linkedin.com
1:19
Life At Alexion: Transforming Lives, Every Day
249 viewsAug 2, 2024
YouTubeAlexion Pharmaceuticals, Inc.
4:23
How will the AstraZeneca and Pfizer COVID vaccines work once they'v…
39.1K viewsJan 25, 2021
YouTubeABC News In-depth
1:02
Meet Alex de Giorgio-Miller: Life at AstraZeneca
2.2K viewsSep 26, 2018
YouTubeastrazeneca
1:57
18K views · 242 reactions | AstraZeneca's COVID-19 vaccine …
18.6K views3 weeks ago
FacebookReuters
1:24
Breakingviews TV: AstraZeneca's big and bold deal
1.5K viewsDec 14, 2020
YouTubeReuters
3:12
How the AstraZeneca COVID-19 vaccine has performed so far
154.3K viewsFeb 27, 2021
YouTubeCBC News: The National
4:16
Full Year 2021 financial results: Pascal Soriot, CEO
6.4K viewsFeb 10, 2022
YouTubeastrazeneca
See more videos
Static thumbnail place holder